Benitec Limited has signed a Memorandum of Understanding with Biomics Biotechnologies Co. Ltd. of Nantong, China to collaborate on RNAi treatments for chronic hepatitis B virus (HBV) infection. The two companies will jointly own the project’s intellectual property, and they will also collaborate on both product development and commercialization. More details...

Stock Symbol: (ASX: BLT)